When host defense goes awry: Modeling sepsis-induced immunosuppression
- PMID: 24052802
- PMCID: PMC3775367
- DOI: 10.1016/j.ddmod.2011.09.001
When host defense goes awry: Modeling sepsis-induced immunosuppression
Abstract
Sepsis is associated with an initial hyperinflammatory state; however, therapeutic trials targeting the inflammatory response have yielded disappointing results. It is now appreciated that septic patients often undergo a period of relative immunosuppression, rendering them susceptible to secondary infections. Interest in this phenomenon has led to the development of animal models to study the immune dysfunction of sepsis. In this review, we analyze the available models of sepsis-induced immunosuppression.
Figures

Similar articles
-
The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.Front Immunol. 2017 May 8;8:493. doi: 10.3389/fimmu.2017.00493. eCollection 2017. Front Immunol. 2017. PMID: 28533774 Free PMC article. Review.
-
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.Cell Death Dis. 2019 Oct 14;10(10):782. doi: 10.1038/s41419-019-2015-1. Cell Death Dis. 2019. PMID: 31611560 Free PMC article. Review.
-
Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.Am J Respir Crit Care Med. 2011 Apr 1;183(7):932-40. doi: 10.1164/rccm.201006-0934OC. Epub 2010 Oct 19. Am J Respir Crit Care Med. 2011. PMID: 20959556
-
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression.J Vis Exp. 2019 Jun 15;(148):10.3791/59386. doi: 10.3791/59386. J Vis Exp. 2019. PMID: 31259890 Free PMC article.
-
New perspectives on immunomodulatory therapy for bacteraemia and sepsis.Int J Antimicrob Agents. 2010 Dec;36 Suppl 2:S70-3. doi: 10.1016/j.ijantimicag.2010.11.008. Epub 2010 Dec 3. Int J Antimicrob Agents. 2010. PMID: 21129935 Review.
Cited by
-
Surgical and immune reconstitution murine models in bone marrow research: Potential for exploring mechanisms in sepsis, trauma and allergy.World J Exp Med. 2017 Aug 20;7(3):58-77. doi: 10.5493/wjem.v7.i3.58. eCollection 2017 Aug 20. World J Exp Med. 2017. PMID: 28890868 Free PMC article. Review.
-
Vitamin D receptor (VDR) on the cell membrane of mouse macrophages participates in the formation of lipopolysaccharide tolerance: mVDR is related to the effect of artesunate to reverse LPS tolerance.Cell Commun Signal. 2023 May 29;21(1):124. doi: 10.1186/s12964-023-01137-w. Cell Commun Signal. 2023. PMID: 37248534 Free PMC article.
-
Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis.Front Immunol. 2022 Aug 5;13:956448. doi: 10.3389/fimmu.2022.956448. eCollection 2022. Front Immunol. 2022. PMID: 35990662 Free PMC article. Review.
-
Inhibition of PTP1B Promotes M2 Polarization via MicroRNA-26a/MKP1 Signaling Pathway in Murine Macrophages.Front Immunol. 2019 Aug 14;10:1930. doi: 10.3389/fimmu.2019.01930. eCollection 2019. Front Immunol. 2019. PMID: 31474996 Free PMC article.
-
Qiang-Xin 1 Formula Prevents Sepsis-Induced Apoptosis in Murine Cardiomyocytes by Suppressing Endoplasmic Reticulum- and Mitochondria-Associated Pathways.Front Pharmacol. 2018 Jul 30;9:818. doi: 10.3389/fphar.2018.00818. eCollection 2018. Front Pharmacol. 2018. PMID: 30104976 Free PMC article.
References
-
- Kochanek KD, et al. Deaths: Preliminary Data for 2009. National Vital Statistics Reports. 2011;59(4):1–51. - PubMed
-
- Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. The New England journal of medicine. 2001;345(19):1368–77. - PubMed
-
- Bernard GR, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England journal of medicine. 2001;344(10):699–709. - PubMed
-
- Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125–8. - PubMed
-
- Cronin L, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995;23(8):1430–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources